PG
NVAX icon

PEAK6 Group’s Novavax NVAX Stock Holding History

PEAK6 Group’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,325
Closed -$222K – 4844
2015
Q4 		$222K Sell
1,325
-3,010
-69% -$463K ﹤0.01% 3357
2015
Q3 		$613K Buy
+4,335
New +$972K ﹤0.01% 2694
2015
Q2 		– Sell
-60
Closed -$10K – 5331
2015
Q1 		$10K Buy
+60
New +$9.74K ﹤0.01% 4576

Other funds holding NVAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

PEAK6 Group's NVAX Position: Q1 2016 in Review

PEAK6 Group sold out of Novavax (NVAX) in Q1 2016, closing a stake of 106 shares — an estimated $18K sold.

PEAK6 Group first reported a position in NVAX in Q1 2015 and held it in 3 quarters. The position peaked at $305K in Q3 2015. 175 funds tracked by Wall St. Rank hold NVAX as of Q1 2016.

  • PEAK6 Group reported no remaining Novavax position as of Q1 2016 after selling out during the quarter.
  • PEAK6 Group sold 106 Novavax shares in Q1 2016, an estimated $18K.
  • PEAK6 Group first reported a position in Novavax in Q1 2015 and held it in 3 quarters.
  • PEAK6 Group's Novavax position peaked at $305K in Q3 2015.
  • 175 funds tracked by Wall St. Rank held Novavax as of Q1 2016.

Based on PEAK6 Group's 13F filing for Q1 2016, filed 13 May 2016.